tiprankstipranks
Trending News
More News >

Solventum upgraded to Buy at Argus on topline growth over past few quarters

Argus analyst David Toung upgraded Solventum (SOLV) to Buy from Hold with a $90 price target. The company has registered sequential topline growth over the past few quarters and showed earnings power with its Q1 results, the analyst tells investors in a research note. While there is still considerable work to restructure and reposition the company after its separation from 3M (MMM), Solventum has transformed into a faster-growing and higher-margin business model under the leadership of CEO Bryan Hanson, Argus added.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1